Literature DB >> 20447870

Immunological and regenerative properties of cord blood stem cells.

Roberto Francese1, Paolo Fiorina.   

Abstract

Cord blood stem cells (CB-SCs) have shown impressive immunological and regenerative capabilities. In this review, we intend to review the state-of-the-art knowledge on CB-SCs characteristics and function as well as immunological and regenerative properties. We report an itemized classification of CB-SCs populations, which is important to better understand which tissues can be replaced using CB-SCs and how the generation of induced pluripotent stem cells from CB-SCs is changing the field. Furthermore, we will discuss new findings on the immunosuppressive capability of CB-SCs in autoimmune disease (e.g., type 1 diabetes). Our review will demonstrate how CB-SCs could become a powerful tool not only for regenerative medicine but for autoimmune and inflammatory diseases as well. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20447870     DOI: 10.1016/j.clim.2010.04.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

1.  Explaining the increased mortality in type 1 diabetes.

Authors:  Chiara Mameli; Sara Mazzantini; Moufida Ben Nasr; Paolo Fiorina; Andrea E Scaramuzza; Gian Vincenzo Zuccotti
Journal:  World J Diabetes       Date:  2015-07-10

Review 2.  Re-engineering islet cell transplantation.

Authors:  Nicoletta Fotino; Carmen Fotino; Antonello Pileggi
Journal:  Pharmacol Res       Date:  2015-03-23       Impact factor: 7.658

Review 3.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 4.  Stem cell-based strategies for the treatment of type 1 diabetes mellitus.

Authors:  Yujie Wen; Bo Chen; Suzanne T Ildstad
Journal:  Expert Opin Biol Ther       Date:  2010-11-29       Impact factor: 4.388

5.  Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.

Authors:  Moufida Ben Nasr; Andrea Vergani; James Avruch; Liye Liu; Eirini Kefaloyianni; Francesca D'Addio; Sara Tezza; Domenico Corradi; Roberto Bassi; Alessandro Valderrama-Vasquez; Vera Usuelli; James Kim; Jamil Azzi; Basset El Essawy; James Markmann; Reza Abdi; Paolo Fiorina
Journal:  Acta Diabetol       Date:  2015-03-27       Impact factor: 4.280

6.  Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10.

Authors:  Suman Kanji; Manjusri Das; Reeva Aggarwal; Jingwei Lu; Matthew Joseph; Sujit Basu; Vincent J Pompili; Hiranmoy Das
Journal:  Stem Cell Res       Date:  2013-11-15       Impact factor: 2.020

Review 7.  Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.

Authors:  Hyun Joon Paek; Courtney Kim; Stuart K Williams
Journal:  World J Diabetes       Date:  2014-06-15

8.  Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Juliana B Novais; Camila Silva-Frade; Marina C Ferrarezi; Alexandre L Andrade; Roberto Gameiro
Journal:  BMC Biotechnol       Date:  2012-05-04       Impact factor: 2.563

Review 9.  Regenerative therapies for diabetic microangiopathy.

Authors:  Roberto Bassi; Alessio Trevisani; Sara Tezza; Moufida Ben Nasr; Francesca Gatti; Andrea Vergani; Antonio Farina; Paolo Fiorina
Journal:  Exp Diabetes Res       Date:  2012-03-29

10.  Inhibition of T cell protein tyrosine phosphatase enhances interleukin-18-dependent hematopoietic stem cell expansion.

Authors:  Annie Bourdeau; Sébastien Trop; Karen M Doody; Daniel J Dumont; Michel L Tremblay; Michel L Tremblayef
Journal:  Stem Cells       Date:  2013-02       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.